229 related articles for article (PubMed ID: 34380511)
1. Expression levels and clinical values of miR-92b-3p in breast cancer.
Du Y; Miao Z; Wang K; Lv Y; Qiu L; Guo L
World J Surg Oncol; 2021 Aug; 19(1):239. PubMed ID: 34380511
[TBL] [Abstract][Full Text] [Related]
2. MiR-92b as a marker for TPF induced chemotherapy response prediction and prognosis evaluation in with advanced oral squamous cell carcinoma patients.
Wen J; Xu H; Liu R; Chen Q; Dai Y; Xu Y
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):24-31. PubMed ID: 32538743
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of miR-330-3p: a novel independent indicator of poor prognosis in human breast cancer.
Wang H; Chen SH; Kong P; Zhang LY; Zhang LL; Zhang NQ; Gu H
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1726-1730. PubMed ID: 29630118
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of a five-microRNA signature in breast carcinoma as a promising biomarker for diagnosis.
Bitaraf A; Babashah S; Garshasbi M
J Clin Lab Anal; 2020 Feb; 34(2):e23063. PubMed ID: 31595567
[TBL] [Abstract][Full Text] [Related]
5. Analysis of miRNA-221 Expression Level in Tumors and Marginal Biopsies from Patients with Breast Cancer (Cross-Sectional Observational Study).
Abak A; Amini S; Estiar MA; Montazeri V; Sakhinia E; Abhari A
Clin Lab; 2018 Jan; 64(1):169-175. PubMed ID: 29479893
[TBL] [Abstract][Full Text] [Related]
6. Combined detection of plasma miR-127-3p and HE4 improves the diagnostic efficacy of breast cancer.
Lu M; Ju S; Shen X; Wang X; Jing R; Yang C; Chu H; Cong H
Cancer Biomark; 2017; 18(2):143-148. PubMed ID: 27983524
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-92b-3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinoma.
Wang C; Uemura M; Tomiyama E; Matsushita M; Koh Y; Nakano K; Hayashi Y; Ishizuya Y; Jingushi K; Kato T; Hatano K; Kawashima A; Ujike T; Nagahara A; Fujita K; Imamura R; Tsujikawa K; Nonomura N
Cancer Sci; 2020 Apr; 111(4):1146-1155. PubMed ID: 31975504
[TBL] [Abstract][Full Text] [Related]
8. Identification of a six-microRNA signature as a potential diagnostic biomarker in breast cancer tissues.
Mahmoudian M; Razmara E; Mahmud Hussen B; Simiyari M; Lotfizadeh N; Motaghed H; Khazraei Monfared A; Montazeri M; Babashah S
J Clin Lab Anal; 2021 Nov; 35(11):e24010. PubMed ID: 34528314
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNA-103a-3p could be a diagnostic and prognostic biomarker for breast cancer.
Liu H; Bian QZ; Zhang W; Cui HB
Oncol Lett; 2022 Jan; 23(1):38. PubMed ID: 34966454
[TBL] [Abstract][Full Text] [Related]
10. Aberrant Expression of miR-142-3p and its Target Gene HMGA1 and FZD7 in Breast Cancer and its Clinical Significance.
Jia XP; Meng LL; Fang JC; Wang HW; Chen J; Zhou J; Wang CN; Jiang WF
Clin Lab; 2018 Jun; 64(6):915-921. PubMed ID: 29945308
[TBL] [Abstract][Full Text] [Related]
11. miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer.
Long M; Zhan M; Xu S; Yang R; Chen W; Zhang S; Shi Y; He Q; Mohan M; Liu Q; Wang J
Mol Cancer; 2017 Oct; 16(1):167. PubMed ID: 29078789
[TBL] [Abstract][Full Text] [Related]
12. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
[TBL] [Abstract][Full Text] [Related]
13. Identification of Serum miR-501-3p and miR-338-3p as Novel Diagnostic Biomarkers for Breast Cancer and Their Target Genes Associated with Immune Infiltration.
Yin L; Ding Y; Wang Y; Wang C; Sun K; Wang L
Int J Gen Med; 2023; 16():1279-1294. PubMed ID: 37077765
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-372-3p promotes the epithelial-mesenchymal transition in breast carcinoma by activating the Wnt pathway.
Fan X; Huang X; Li Z; Ma X
J BUON; 2018; 23(5):1309-1315. PubMed ID: 30570852
[TBL] [Abstract][Full Text] [Related]
15. Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
Sun T; Song Y; Yu H; Luo X
Cancer Biol Ther; 2019; 20(6):760-773. PubMed ID: 30810442
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of microRNA-92b-3p suppresses proliferation, migration, and invasion of gastric cancer SGC-7901 cells by targeting Homeobox D10.
Li C; Huo B; Wang Y; Cheng C
J Cell Biochem; 2019 Oct; 120(10):17405-17412. PubMed ID: 31106881
[TBL] [Abstract][Full Text] [Related]
17. Plasma Circulating Mirnas Profiling for Identification of Potential Breast Cancer Early Detection Biomarkers.
Jusoh AR; Mohan SV; Lu Ping T; Tengku Din TADAAB; Haron J; Romli RC; Jaafar H; Nafi SN; Tuan Salwani TI; Yahya MM
Asian Pac J Cancer Prev; 2021 May; 22(5):1375-1381. PubMed ID: 34048164
[TBL] [Abstract][Full Text] [Related]
18. Competitive Endogenous Role of the LINC00511/miR-185-3p Axis and miR-301a-3p From Liquid Biopsy as Molecular Markers for Breast Cancer Diagnosis.
Mahmoud MM; Sanad EF; Elshimy RAA; Hamdy NM
Front Oncol; 2021; 11():749753. PubMed ID: 34745973
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of MiR-1908-3p as a novel serum biomarker for breast cancer and analysis its oncogenic function and target genes.
Zhu Y; Wang Q; Xia Y; Xiong X; Weng S; Ni H; Ye Y; Chen L; Lin J; Chen Y; Niu H; Chen X; Lin Y
BMC Cancer; 2020 Jul; 20(1):644. PubMed ID: 32650755
[TBL] [Abstract][Full Text] [Related]
20. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
Chen L; Chu F; Cao Y; Shao J; Wang F
Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]